Abstract
To assess the safety and efficacy of percutaneous sclerotherapy of slow-flow vulvar vascular malformations. An IRB-approved retrospective review was undertaken of all patients who underwent percutaneous sclerotherapy of slow-flow vulvar vascular malformations between January 2008 and August 2017. Patient demographics, lesion characteristics, procedural factors, and clinical outcomes were identified through a review of the electronic medical record and relevant imaging. Seven female patients (ages 7-32 years) with slow-flow vulvar vascular malformations underwent a total of 14 percutaneous sclerotherapy treatments using the 3% sodium tetradecyl sulfate foam technique. Two cases were associated with Klippel-Trénaunay syndrome and one with Servelle-Martorell syndrome. Presenting symptoms included generalized pain or discomfort (n = 6), dyspareunia (n = 1), voiding difficulties (n = 1), and cosmetic concerns (n = 1). All sclerotherapy procedures were technically successful. Clinical follow-up was available in six patients. Two patients reported near-complete resolution of symptoms after a single treatment. Three patients experienced initial relief but developed symptomatic recurrence after one year and required repeat treatment with subsequent resolution of symptoms. One patient experienced a gradual improvement in symptoms requiring a total of five treatments. One procedure (7.1%) resulted in minor labial cutaneous ulceration which resolved with conservative management. There were no major complications. Percutaneous sclerotherapy of slow-flow vulvar vascular malformations proved safe and effective in this limited cohort. While repeat therapy was necessary in the majority of cases, nearly all patients experienced durable symptomatic relief.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call